A brain-to-blood carrier-mediated transport system for small, N-tyrosinated peptides.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1984-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0091-3057(84)80077-5PMID 6151670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism.

  1984cited by this paper
• Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.

  1984cited by this paper
• Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia.

  1983cited by this paper
• ALUMINIUM INCREASES PERMEABILITY OF THE BLOOD-BRAIN BARRIER TO LABELLED DSIP AND β-ENDORPHIN: POSSIBLE IMPLICATIONS FOR SENILE AND DIALYSIS DEMENTIA

  1983cited by this paper
• Choroid-Plexus Transport of Enkephalins and Other Neuropeptides

  1983cited by this paper
• Delta sleep-inducing peptide crosses the blood-brain-barrier in dogs: some correlations with protein binding.

  1982cited by this paper
• Differential penetration of DSIP peptides into rat brain.

  1982cited by this paper
• Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain.

  1982cited by this paper
• Selective effects of α-MSH and MIF-1 on the blood-brain barrier

  1981cited by this paper
• Selective effects of alpha-MSH and MIF-1 on the blood-brain barrier.

  1981cited by this paper
• Mediation of Angiotensin-Induced Drinking Behavior by the Circumventricular Organs

  1981cited by this paper
• The satiety effect of cholecystokinin: a progress report.

  1981cited by this paper
• Radioimmunoassayable N-Tyr-MIF-1-like activity in rat brain is increased by pinealectomy.

  1981cited by this paper
• Entry of opioid peptides into the central nervous system.

  1980cited by this paper
• Cholecystokinin acts on the hypothalamic "noradrenergic system" involved in feeding.

  1980cited by this paper
• Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.

  1980cited by this paper
• Low permeation of systemically administered human beta-endorphin into rabbit brain measured by radioimmunoassays differentiating human and rabbit beta-endorphin.

  1980cited by this paper
• beta-Endorphin: stability, clearance behavior, and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits.

  1980cited by this paper
• Low permeation of systemically administered human ß-endorphin into rabbit brain measured by radioimmunoassays differentiating human and rabbit ß-endorphin

  1980cited by this paper
• CNS effects of peripherally administered brain peptides.

  1979cited by this paper
• Melanotropic peptides increase permeability of plasma/cerebrospinal fluid barrier.

  1978cited by this paper
• The accumulation of (3H) enkephalinamide (2-D-alanine-5-methioninamide) in rat brain tissues.

  1978cited by this paper
• An enzymatically stable peptide with activity in the central nervous system: its penetration through the blood-CSF barrier.

  1977cited by this paper
• Distribution of 3H-alpha-MSH in rat brain.

  1976cited by this paper
• Possible role of insulin in the transport of tyrosine and tryptophan from blood to brain.

  1976cited by this paper
• Distribution of 3H-α-MSH in rat brain

  1976cited by this paper
• A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain.

  1967cited by this paper

• The Mechanism and Latest Research Progress of Blood–Brain Barrier Breakthrough

  2024cites this paper
• Designing peptide nanoparticles for efficient brain delivery.

  2020cites this paper
• Modest Blood-Brain Barrier Permeability of the Cyclodextrin Kleptose: Modification by Efflux and Luminal Surface Binding

  2019cites this paper
• Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression

  2018cites this paper
• Peptides and the blood-brain barrier.

  2015cites this paper
• Peptides: important tools for the treatment of central nervous system disorders.

  2011cites this paper
• Concepts for biologically active peptides.

  2010cites this paper
• Evolution of neuropeptide concepts illustrated by MIF-1 and MSH

  2009cites this paper
• Evidence for presence of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in human brain cortex.

  2009cites this paper
• From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.

  2007cites this paper
• Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1.

  2007cites this paper
• The CNS as a target for peptides and peptide-based drugs

  2006cites this paper
• Effect of neurotransmitters on the system that transports Tyr-MIF-1 and the enkephalins across the blood-brain barrier: a dominant role for serotonin

  2004cites this paper
• Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells

  2004cites this paper
• Efflux Mechanisms in the Central Nervous System: A Powerful Influence on Drug Distribution within the Brain

  2004cites this paper
• Relation of beta-casomorphin to apnea in sudden infant death syndrome.

  2003cites this paper
• Relation of β-casomorphin to apnea in sudden infant death syndrome

  2003cites this paper
• Endomorphins, Met-enkephalin, Tyr-MIF-1, and the P-glycoprotein efflux system.

  2002cites this paper
• Saturable brain-to-blood transport of endomorphins

  2001cites this paper
• Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein.

  2001cites this paper
• Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.

  2000cites this paper
• Improved bioavailability to the brain of glycosylated Met-enkephalin analogs.

  2000cites this paper
• Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders.

  1999cites this paper
• Peptide drug delivery into the central nervous system.

  1998cites this paper
• The enzymatic degradation and transport of leucine-enkephalin and 4-imidazolidinone enkephalin prodrugs at the blood-brain barrier

  1998cites this paper
• Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration.

  1997cites this paper
• Bioavailability and transport of peptides and peptide drugs into the brain.

  1997cites this paper
• Periventricular penetration and disappearance of ICV Tyr-MIF-1, DAMGO, tyrosine, and albumin.

  1996cites this paper
• The History of Neuropeptide Research: Version 5.a

  1996cites this paper
• Passage of peptides across the blood-brain barrier: pathophysiological perspectives.

  1996cites this paper
• Polyamine Modification Increases the Permeability of Proteins at the Blood‐Nerve and Blood‐Brain Barriers

  1996cites this paper
• Transport of Pituitary Adenylate Cyclase‐Activating Polypeptide Across the Blood‐Brain Barrier and the Prevention of Ischemia‐Induced Death of Hippocampal Neurons

  1996cites this paper
• Peptide Transport System-1

  1995cites this paper
• Melanocyte‐Stimulating Hormone Release‐Inhibiting Factor‐1 (MIF‐1) Can Be Formed from Tyr‐MIF‐1 in Brain Mitochondria but Not in Brain Homogenate

  1995cites this paper
• Macromolecular permeability across the blood-nerve and blood-brain barriers.

  1994cites this paper
• Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma.

  1994cites this paper
• The Tyr-MIF-1 family of peptides.

  1994cites this paper
• Leucine-enkephalin metabolism in brain microvessel endothelial cells.

  1994cites this paper
• Novel Concepts from Novel Peptides

  1994cites this paper
• Leucine Enkephalin Effects on Brain Microvessel Endothelial Cell Monolayer Permeability

  1994cites this paper
• Leucine enkephalin effects on paracellular and transcellular permeation pathways across brain microvessel endothelial cell monolayers.

  1994cites this paper
• Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine.

  1994cites this paper
• Peptides and blood-brain barrier transport.

  1993cites this paper
• Uptake, content, regulation of plasma concentrations, and binding of Tyr-MIF-1 by the adrenals.

  1993cites this paper
• Drug transport across the blood-brain barrier

  1993cites this paper
• Chapter 21: Bidirectional passage of peptides across the blood-brain barrier

  1992cites this paper
• Drug transport across the blood — brain barrier

  1992cites this paper
• Bidirectional passage of peptides across the blood-brain barrier.

  1992cites this paper
• Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).

  1992cites this paper
• Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration.

  1991cites this paper
• Molecular anatomy of the blood-brain barrier as defined by immunocytochemistry.

  1991cites this paper
• Peptide transport across the blood-brain barrier☆

  1990cites this paper
• A Decade of Changing Perceptions about Neuropeptides

  1990cites this paper
• Peptide transport systems for opiates across the blood-brain barrier.

  1990cites this paper
• Exchange of peptides between the circulation and the nervous system: role of the blood-brain barrier.

  1990cites this paper
• Uptake of peptides containing Tyr-Pro by human and mouse erythrocytes.

  1990cites this paper
• Quantifying carrier-mediated transport of peptides from the brain to the blood.

  1989cites this paper
• Passage of Tyr-MIF-1 from blood to brain.

  1989cites this paper
• Isolation of tyrosine-melanocyte-stimulating hormone release-inhibiting factor 1 from bovine brain tissue.

  1989cites this paper
• Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier.

  1989cites this paper
• Twenty‐one hormones fail to inhibit the brain to blood transport system for Tyr‐MIF‐1 and the enkephalins in mice

  1988cites this paper
• Analgesia and the blood-brain barrier transport system for Tyr-MIF-1/enkephalins: evidence for a dissociation.

  1988cites this paper
• Passage of delta sleep-inducing peptide (DSIP) across the blood-cerebrospinal fluid barrier.

  1988cites this paper
• Improvement of cocaine-induced neuromodulator deficits by the neuronutrient Tropamine.

  1988cites this paper
• Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE.

  1988cites this paper
• Interactions between the blood-brain barrier and endogenous peptides: emerging clinical implications.

  1988cites this paper
• Peptides and the blood brain barrier: penetration and modulating influences

  1988cites this paper
• Systemic methionine-enkephalin evokes cardiostimulatory responses in the human.

  1987cites this paper
• Introduction to the article by Kastin et al. on some principles in the peptide field: Possible considerations for immunology

  1987cites this paper
• Saturable transport of peptides across the blood-brain barrier.

  1987cites this paper
• Possible therapeutic implications of the effects of some peptides on the brain.

  1987cites this paper
• Some principles in the peptide field.

  1987cites this paper
• Tyr-MIF-1 and Met-enkephalin share a saturable blood-brain barrier transport system.

  1987cites this paper
• Hypophysectomy increases TYR-MIF-1-like immunoreactivity in rat plasma.

  1987cites this paper
• Carrier‐mediated transport of vasorpressin across the blood‐brain barrier of the mouse

  1987cites this paper
• Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier.

  1986cites this paper
• Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1.

  1986cites this paper
• Selective transport across the blood-brain barrier.

  1986cites this paper
• Entry of DSIP peptides into dog CSF: role of physicochemical and pharmacokinetic parameters.

  1986cites this paper
• Modulation of the carrier-mediated transport of the Tyr-MIF-1 across the blood-brain barrier by essential amino acids.

  1986cites this paper
• Binding of Tyr-MIF-1 to isolated brain capillaries.

  1986cites this paper
• Ventilatory response to intravenous methionine enkephalin in awake dogs.

  1985cites this paper
• Modulation of immunoactive levels of DSIP and blood‐brain barrier permeability by lighting and diurnal rhythm

  1985cites this paper
• Aging and the blood-brain barrier: changes in the carrier-mediated transport of peptides in rats.

  1985cites this paper
• Permeability of the blood-brain barrier to neuropeptides: the case for penetration.

  1985cites this paper
• Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability.

  1985cites this paper
• Modulation of immunoactive levels of DSIP and blood-brain permeability by lighting and diurnal rhythm.

  1985cites this paper
• Transport of thyroxine across the blood-brain barrier is directed primarily from brain to blood in the mouse.

  1985cites this paper
• Short Communication Endomorphins, Met-enkephalin, Tyr-mif-1, and the P-glycoprotein Efflux System after Injection of Endomorphin-1 (tyr-pro-trp-phe-nh 2 ), Endo- Morphin-2 (tyr-pro-phe-phe-nh 2 ), Met-enkephalin (tyr-gly-gly- Phe-met-oh), and Tyr-mif-1 (tyr-pro-leu-gly-nh 2 ) into the Lateral Ventri

  year unknowncites this paper